Industry NewsAbcam acquires gene-editing platform and oncology product portfolio from US biotech Applied StemCell
Product NewsAbcam and BrickBio announce partnership to incorporate conjugation-ready sites into antibodies
Industry NewsAbcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knockout Cell Lines and Lysates Portfolio
Product NewsAbcam plc Exercises Exclusivity Provision of License and Supply Agreement with Horizon Discovery
Industry NewsAbcam Raises Antibody Validation Standards to Improve Quality for Life Science Researchers
Product NewsAbcam Introduces Alexa Fluor® 680/790 Secondary Antibodies for Fluorescent Western Blotting
Product NewsAbcam’s New Alexa Fluor Secondary Antibodies Provide Increased Selection for Multi-Color Staining
